Today’s news
Pfizer's Trispecific Antibody Shows Promise in Atopic Dermatitis Study
Phase 2 trial results indicate potential new treatment for moderate to severe cases

Utah Woman's Decade-Long Struggle with Rare Disease Highlights Diagnostic Challenges
Misty Segrest's journey to diagnosis with systemic mastocytosis underscores the need for greater awareness and advanced technologies to identify uncommon conditions.
FDA Recalls Popular Easter Candy Due to Undeclared Allergens
Premium Food Jordan Almonds pulled from shelves in New York and New Jersey
Recent news
Mar. 7, 2026
Frito-Lay Recalls Miss Vickies Dill Pickle Chips Due to Milk Allergen
Consumers with milk allergies or sensitivities advised not to consume the recalled product.
Mar. 6, 2026
Premium Foods Recalls Jordan Almonds Over Undeclared Allergens
The Easter candy was missing wheat and color additive information on the label.
Mar. 5, 2026
FDA Recalls Savannah Bee Company Barbecue Sauce Over Allergen Concerns
Bottles labeled as Honey BBQ Sauce-Mustard were accidentally filled with Honey BBQ Sauce-Sweet, resulting in undeclared wheat and soy.
Mar. 5, 2026
Investigational Drug Verekitug Improves Chronic Rhinosinusitis With Nasal Polyps
Phase 2 trial shows verekitug reduced nasal polyp size and need for surgery compared to placebo.
Mar. 5, 2026
Warming Climate Extends Allergy Season in North Carolina
Longer growing seasons mean more pollen, worse symptoms for Triangle residents
Mar. 5, 2026
Hiker Airlifted After Allergic Reaction to Fire Ants on California Trail
The female hiker suffered a severe reaction and had to be rescued by helicopter.
Mar. 5, 2026
Savannah Bee Company Recalls Barbecue Sauce Over Allergen Risk
Customers urged to check their pantries for the affected product.
Mar. 4, 2026
Reddit Eczema Communities Favor Evidence-Based Discussions
Study finds community engagement on Reddit tends to prioritize posts aligned with dermatologist guidelines over misinformation.
Mar. 3, 2026
Savannah Bee Company recalls Honey BBQ Sauce-Mustard over undeclared allergens
The recall affects 16-ounce bottles with a best-by date of May 16, 2027.
Mar. 3, 2026
Intellia Therapeutics Presents Longer-Term Clinical Data For Lonvoguran Ziclumeran
Promising results for one-time gene editing therapy to treat hereditary angioedema
Mar. 3, 2026
Savannah Bee Company Recalls Honey BBQ Sauce for Potential Allergen Contamination
The recall was initiated after a customer notified the company that the 'Honey BBQ Sauce-Mustard' was mislabeled.
Mar. 3, 2026
Nearly Half of Kids With Immunodeficiency Carry Incorrect Drug Allergy Labels
Allergy testing often finds no true allergy, opening up treatment options, but few children undergo evaluation.
Mar. 3, 2026
DBV Technologies Highlights Positive Phase 3 VITESSE Study Data at AAAAI 2026 Meeting
Significant increases in eliciting dose seen in children treated with VIASKIN Peanut Patch compared to placebo
Mar. 3, 2026
Atrium Health Navicent Wellness Center Offers Allergy Season Workout Tips, Hosts 5K
Wellness center provides indoor options and invites community to free visits and upcoming events.
Mar. 3, 2026
Oklahoma Pollen Levels Soar, but Relief is on the Way
Tree allergens from cedars, elms, and maples causing issues for Oklahomans, but a weather system is expected to bring pollen levels down soon.
Mar. 3, 2026
Pork Belly Product Recalled Due to Allergen
Gourmet Trends Kitchen recalls 800 pounds of pork belly over undeclared wheat allergen
Mar. 2, 2026
Savannah Bee Company Recalls Honey BBQ Sauce Due to Undeclared Allergens
The mislabeled sauce poses a life-threatening risk for those with wheat and soy allergies.
Feb. 27, 2026
Excellergy Presents New Data on Allergic Effector Cell Control
Announces First Subjects Dosed in Phase 1 DISARM Trial for Investigational Allergy Therapy Exl-111
Feb. 27, 2026
Environmental Allergens Pose Greater Asthma Risk for Older Adults
New research suggests older adults are more vulnerable to asthma-promoting effects of environmental estrogens.
Feb. 27, 2026
Ionis Pharmaceuticals to Present New Hereditary Angioedema Drug Data
The company will showcase findings on its approved DAWNZERA treatment at the 2026 AAAAI Annual Meeting.